Search

Author/Creator Macdonell, Richard

1. Guillain‐Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self‐controlled case series. Issue 6 (7th April 2014)

Authors:
Crawford, Nigel W; Cheng, Allen; Andrews, Nick; Charles, Patrick G; Clothier, Hazel J; Day, Bruce; Day, Timothy; Gates, Peter; Macdonell, Richard; Roberts, Les; Rodriguez‐Casero, Victoria; Wijeratne, Tissa; Kiers, Lynette
Journal:
Medical journal of Australia
Issue:
Volume 200:Issue 6(2014)
Page Start:
321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study. (January 2019)

Authors:
Miller, Aaron E.; Xu, Xianhao; Macdonell, Richard; Vucic, Steve; Truffinet, Philippe; Benamor, Myriam; Thangavelu, Karthinathan; Freedman, Mark S.
Journal:
Journal of clinical neuroscience
Issue:
Volume 59(2019)
Page Start:
229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prediction of multiple sclerosis outcomes when switching to ocrelizumab. (May 2022)

Authors:
Zhong, Michael; van der Walt, Anneke; Stankovich, Jim; Kalincik, Tomas; Buzzard, Katherine; Skibina, Olga; Boz, Cavit; Hodgkinson, Suzanne; Slee, Mark; Lechner-Scott, Jeannette; Macdonell, Richard; Prevost, Julie; Kuhle, Jens; Laureys, Guy; Van Hijfte, Liesbeth; Alroughani, Raed; Kermode, Allan G...
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 6(2022)
Page Start:
958
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data. Issue 2 (4th July 2022)

Authors:
Hardy, Todd A; Parratt, John; Beadnall, Heidi; Blum, Stefan; Macdonell, Richard; Beran, Roy G; Shuey, Neil; Lee, Andrew; Carroll, William; Shaw, Cameron; Worrell, Richard; Moody, Jana; Sedhom, Mamdouh; Barnett, Michael; Vucic, Steve
Journal:
BMJ neurology open
Issue:
Volume 4:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 099  Safety and effectiveness of dimethyl fumarate in multiple sclerosis patients treated over 5 years. Issue 6 (27th May 2022)

Authors:
Giles, Kathryn; Balashov, Konstatin; Macdonell, Richard; Windsheimer, Joerg; Okai, Annette; Martinez, Mikel; Mokliatchouk, Oksana; Lyons, Jennifer; Kapadia, Shivani
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 93:Issue 6(2022)
Page Start:
A131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

Authors:
Sharmin, Sifat; Bovis, Francesca; Malpas, Charles; Horakova, Dana; Havrdova, Eva Kubala; Izquierdo, Guillermo; Eichau, Sara; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Onofrj, Marco; Lugaresi, Alessandra; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro...
Journal:
European journal of neurology
Issue:
Volume 29:Number 8(2022)
Page Start:
2321
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Psychometric deficits in autoimmune encephalitis: A retrospective study from the Australian Autoimmune Encephalitis Consortium. (20th May 2022)

Authors:
Griffith, Sarah; Wesselingh, Robb; Broadley, James; O'Shea, Marie; Kyndt, Chris; Meade, Catherine; Long, Brian; Seneviratne, Udaya; Reidy, Natalie; Bourke, Robert; Buzzard, Katherine; D'Souza, Wendyl; Macdonell, Richard; Brodtmann, Amy; Butzkueven, Helmut; O'Brien, Terence J.; Alpitsis, Rubina; M...
Journal:
European journal of neurology
Issue:
Volume 29:Number 8(2022)
Page Start:
2355
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. Issue 12 (19th October 2022)

Authors:
Zhu, Chao; Zhou, Zhen; Roos, Izanne; Merlo, Daniel; Kalincik, Tomas; Ozakbas,, Serkan; Skibina, Olga; Kuhle, Jens; Hodgkinson, Suzanne; Boz, Cavit; Alroughani, Raed; Lechner-Scott, Jeannette; Barnett, Michael; Izquierdo, Guillermo; Prat, Alexandre; Horakova, Dana; Kubala Havrdova, Eva; Macdonell,...
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 93:Issue 12(2022)
Page Start:
1330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. JC virus conversion rates in natalizumab treated patients: the melbourne longitudinal cohort study. Issue 5 (8th May 2017)

Authors:
Dwyer, Chris; Jokubaitis, Vilija; Baker, Josephine; Haartsen, Jodi; Rath, Louise; Coleman, Jennifer; Fryer, Kylie; Macintyre, Jennifer; Cartwright, Adriana; Skibina, Olga; Macdonell, Richard; Butler, Ernest; Shuey, Neil; Butzkueven, Helmut; Kilpatrick, Trevor; Walt, Anneke van der
Journal:
Journal of neurology, neurosurgery and psychiatry
Issue:
Volume 88:Issue 5(2017)
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗